Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, January 28, 2012

JCO Editorial: Moving Beyond Anti–Vascular Endothelial Growth Factor Therapy in Ovarian Cancer (Avastin,AMG-386)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.